{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-044380","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2023-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.996548+00:00","generated_at":"2026-06-17T03:03:15.378373+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nutex Health enters $100M pre-paid advance with Yorkville; initial $15M at 90% of face","bullets":["Aggregate commitment $100M over 18 months; initial $15M funded, second $10M contingent on VWAP >= $0.60.","Purchase price 90% of face; conversion price floor $0.1851; shares issued at lower of VWAP or 92% of two lowest daily VWAPs.","Yorkville capped at 4.99% beneficial ownership; aggregate issuances limited to 19.9% of shares (Nasdaq Cap); no short sales.","Lincoln Park Capital waives its equity line while PPA outstanding >$1M; Nutex agrees not to terminate LPCF for 24 months.","Proceeds to support growth, acquisitions, potential stock buybacks, and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-044380","json":"https://secwatch.observer/filing/0001104659-23-044380.json","markdown":"https://secwatch.observer/filing/0001104659-23-044380.md","text":"https://secwatch.observer/filing/0001104659-23-044380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000110465923044380/0001104659-23-044380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000110465923044380/tm2310592d8_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T03:03:15.378373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bf3871cd1a173ba67b12f0fa52cee43c9dc4c13e","claim":"Nutex Health Inc. entered into Pre-Paid Advance Agreement (PPA) with YA II PN, Ltd. valued at Up to $25,000,000 initial Pre-Paid Advance, aggregate limit $100,000,000 (effective 2023-04-11).","evidence_excerpt":"On April 11, 2023, Nutex Health Inc. (the “Company”) entered into a Pre-Paid Advance Agreement (the “PPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Investor”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000110465923044380/0001104659-23-044380-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"YA II PN, Ltd."},{"label":"Value","value":"Up to $25,000,000 initial Pre-Paid Advance, aggregate limit $100,000,000"},{"label":"Effective","value":"2023-04-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}